| 2026-05-21 |
COSU6448894610 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4651.0 kg |
870880
|
BUDESONIDE INHALATION SUSPENSION, 0.5 MG/2M L |
| 2026-05-21 |
COSU6448895330 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4224.0 kg |
870880
|
BUDESONIDE INHALATION SUSPENSION, 0.5 MG/2M L |
| 2026-05-21 |
COSU6448933140 |
OHM LABORATORIES INC |
6083.0 kg |
310510
|
XXXXXXXXXX DELAYED RELEASE TABLETS 20MG |
| 2026-05-12 |
COSU6448338480 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4699.0 kg |
200570
|
ALBUTEROL SULFATE INHALATION SOLUTION, 0.083%BASE (US) |
| 2026-05-12 |
COSU6448337780 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4633.0 kg |
870880
|
BUDESONIDE INHALATION SUSPENSION, 0.25 MG/2ML;ALBUTEROL SULF BUDESONIDE INHALATION SUSPENSION, 0.25 MG/2ML;ALBUTEROL SULF |
| 2026-05-12 |
COSU6448338470 |
SUN PHARMACEUTICAL INDUSTRIES INC |
7535.0 kg |
293911
|
BUPRENORPHINE HCL 2MG AND NALOXONE HCL 0.5MG SL TABLETS (BUP BUPRENORPHINE HCL 2MG AND NALOXONE HCL 0.5MG SL TABLETS (BUP BUPRENORPHINE HCL 2MG AND NALOXONE HCL 0.5MG SL TABLETS (BUP BUPRENORPHINE HCL 2MG AND NALOXONE HCL 0.5MG SL TABLETS (BUP |
| 2026-04-26 |
COSU6447237750 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5430.0 kg |
281420.0
|
ALBUTEROL SULFATE INHALATION SOLUTION,.% |
| 2026-04-26 |
COSU6447237760 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4432.0 kg |
870880.0
|
BUDESONIDE INHALATION SUSPENSION, . MG/ML; ALBUTEROL SULFA |
| 2026-04-15 |
COSU6446066870 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5430.0 kg |
310430.0
|
ALBUTEROL SULFATE INHALATION |
| 2026-04-10 |
COSU6445248980 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4583.0 kg |
870880.0
|
BUDESONIDE INHALATION SUSPENSION, MG/ML |
| 2026-04-10 |
COSU6445249120 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4699.0 kg |
200570.0
|
ALBUTEROL SULFATE INHALATION SOLUTION, . % BASE (US) |
| 2026-04-10 |
COSU6445296710 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4699.0 kg |
200570.0
|
ALBUTEROL SULFATE INHALATION SOLUTION, . % BASE (US) |
| 2026-04-09 |
COSU6444822100 |
GRANULES PHARMACEUTICALS INC |
6588.0 kg |
291229.0
|
METOPROLOL SUCCINATE USP |
| 2026-04-06 |
COSU6444806530 |
OHM LABORATORIES INC |
6091.0 kg |
310510.0
|
OMEPRAZOLE DELAYED RELEASE TABLETS MG |
| 2026-01-27 |
COSU6439733120 |
OHM LABORATORIES INC |
5462.0 kg |
310510.0
|
OMEPRAZOLE DELAYED RELEASE TABLETS MG |
| 2026-01-04 |
COSU6435968140 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5430.0 kg |
281420.0
|
ALBUTEROL SULFATE INHALATION SOLUTION, . % |
| 2026-01-04 |
COSU6435968250 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5280.0 kg |
281420.0
|
ALBUTEROL SULFATE INHALATION SOLUTION, . % |
| 2026-01-04 |
COSU6435968380 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4224.0 kg |
870880.0
|
BUDESONIDE INHALATION SUSPENSION, . MG/ ML |
| 2026-01-04 |
COSU6435968440 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5185.0 kg |
870880.0
|
BUDESONIDE INHALATION SUSPENSION, . MG/ ML |
| 2025-10-21 |
COSU6429008430 |
GRANULES PHARMACEUTICALS INC |
6624.0 kg |
291229.0
|
METOPROLOL SUCCINATE USP |
| 2025-10-18 |
COSU6429008431 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4776.0 kg |
281420.0
|
IPRATROPIUM BROMIDE & ALBUTEROL SULFATE INHA LATION SOLUTION |
| 2025-10-18 |
COSU6429008432 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4859.0 kg |
281420.0
|
IPRATROPIUM BROMIDE & ALBUTEROL SULFATE INHA LATION SOLUTION |
| 2025-10-18 |
COSU6429008434 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5144.0 kg |
300610.0
|
CIPROFLOXACIN ( . %) AND DEXAMETHASONE ( . % ) STERILE OTIC |
| 2025-10-18 |
COSU6429008433 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5350.0 kg |
300610.0
|
CIPROFLOXACIN ( . %) AND DEXAMETHASONE ( . % ) STERILE OTIC |
| 2025-10-18 |
COSU6429008435 |
SUN PHARMACEUTICAL INDUSTRIES INC |
5000.0 kg |
300610.0
|
CIPROFLOXACIN ( . %) AND DEXAMETHASONE ( . % ) STERILE OTIC |
| 2025-10-18 |
COSU6429008436 |
SUN PHARMACEUTICAL INDUSTRIES INC |
4796.0 kg |
|
CIPROFLOXACIN ( . %) AND DEXAMETHASONE ( . % ) STERI |
| 2025-10-18 |
COSU6429131000 |
SUN PHARMACEUTICAL INDUSTRIES INC |
10940.0 kg |
280511.0
|
DIVALPROEX SODIUM DELAYED- RELEASE TABLETS U SP, MG |
| 2025-06-18 |
COSU6416912810 |
GRANULES PHARMACEUTICALS INC |
6533.0 kg |
291229
|
METOPROLOL SUCCINATE USP |
| 2025-05-31 |
COSU6415654740 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4177.0 kg |
|
BUDESONIDE INHALATION |
| 2025-05-31 |
COSU6415654760 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4177.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS |
| 2025-05-28 |
COSU6414943650 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4776.0 kg |
282759
|
IPRATROPIUM BROMIDE & ALBUTEROL SULFATE INHA LATION |
| 2025-05-28 |
COSU6414942520 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4641.0 kg |
200570
|
ALBUTEROL SULFATE INHALATION SOLUTION,0.083% BASE (US) |
| 2025-04-22 |
COSU6411822160 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4224.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS |
| 2025-04-22 |
COSU6411824560 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4711.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS |
| 2025-04-02 |
COSU6410029510 |
GRANULES PHARMACEUTICALS INC |
5148.0 kg |
291229
|
METOPROLOL SUCCINATE USP |
| 2025-03-14 |
COSU6409157830 |
SUN PHARMACEUTICALS INDUSTRIES INC |
5017.0 kg |
680790
|
ASPHALT |
| 2025-03-14 |
COSU6409157839 |
SUN PHARMACEUTICALS INDUSTRIES INC |
5430.0 kg |
680790
|
ASPHALT |
| 2025-02-09 |
COSU6406197100 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4699.0 kg |
200570
|
ALBUTEROL SULFATE INHALATION SOLUTION,0.083 % BASE (US) |
| 2024-11-15 |
COSU6398441860 |
SUN PHARMACEUTICALS INDUSTRIES INC |
4967.0 kg |
310430
|
ALBUTEROL SULFATE INHALATION |
| 2024-10-22 |
COSU6395948160 |
SUN PHARMACEUTICALS INDUSTRIES INC |
5430.0 kg |
310430
|
ALBUTEROL SULFATE INHALATION |
| 2024-08-29 |
COSU6390675270 |
SUN PHARMACEUTICALS INDUSTRIES INC |
5247.0 kg |
281420
|
ALBUTEROL SULFATE INHALATION SOLUTION, |